Immunology



Simple Blood Test Predicts Neuroendocrine Tumor Response to Radiopharmaceutical Therapy
A new study has revealed that a simple blood test can supply doctors with crucial information to ascertain if peptide receptor radionuclide therapy (PRRT) is likely to be effective in patients with neuroendocrine cancer. More...11 Apr 2023

Fast, Fully Automated Microfluidic Device Predicts Effectiveness of Cancer Treatment 
A microfluidic device can quickly and automatically predict the effectiveness of cancer treatment by using a tiny amount of cells from biopsies and without the need for specialized technical staff. More...
03 Apr 2023

Genetic Test Predicts Whether Bowel Cancer Patients Can Benefit From Chemotherapy
Researchers have discovered that a genetic test, an established part of standard care in the UK and globally to predict patients' responses to other targeted cancer drugs, can also predict whether chemotherapy will work for bowel cancer patients. This discovery could aid in sparing patients from unnecessary toxicity and debilitating side effects by avoiding treatments that will not benefit them. More...06 Mar 2023

Ground-Breaking Test Assesses Expansion and Persistence of CAR-T Therapy in Cancer Patients
Research has shown that the persistence and expansion of CAR-T therapy are important indicators of how long the therapy can remain effective in the patient. Now, a ground-breaking test provides clinicians with an accurate and comprehensive assessment of the CAR-T cell population in the patient's body and offers insights to therapy effectiveness. More...21 Feb 2023

Study of Emerging Pathogens to Better Understand Influenza-Antibody Interactions Could Improve Diagnostics
For long, scientists have wondered why aquatic birds, particularly ducks, which are carriers of influenza viruses rarely become severely ill themselves. They are yet to find the answer to how their immune systems can be a reservoir for such a highly infectious and pathogenic virus, but still remain mostly unharmed. Now, a team of investigators will attempt to answer these questions as part of an ambitious, three-year project. More...30 Jan 2023
In Other News
FDA Cleared Sepsis Test Becomes First in New Class of ED-Focused Diagnostic Tools
Cooperativity Between Myeloid Lineages Promotes Langerhans Cell Histiocytosis Pathology
Impact of Preanalytical Factors on Calprotectin Concentration in Stool
Antiphospholipid Antibodies in Patients With Unexplained Articular Manifestations
CSF Immunoassays Aid Diagnosis of Early Alzheimer’s Disease
Autoimmunity-Associated T Cell Receptors Recognize HLA-Variant-Bound Peptides
Blood Test for Myocarditis Detects Heart Inflammation
Antiphospholipid Antibodies Evaluated in Autoimmune Thyroid Diseases
Interleukins and Vitamin D Evaluated in Women With Graves' Disease
More Evidence for Epstein - Barr virus' Role in MS Found
Immune Reaction to Gut Bacterium May Trigger Rheumatoid Arthritis
Immunoaffinity Technology Distinguishes Between Lyme Disease Infection States and Tracks Treatment Response
Macadamia Nut-Specific IgE Levels Predict Anaphylaxis
Immune Regulators Predict Severity of Plasmodium vivax Malaria
Elevated Antibody Levels Identified in Chronic Fatigue Syndrome Patients
PD-L1 Expression Associated With Poorer Survival in Anal Squamous Cell Carcinoma
Diagnostic Assay Identifies Which Species Patients with Fish Allergy Can Tolerate
Single Test Predicts Cancer Recurrence and Side-Effects of Immunotherapy
Several Biomarkers Predict Progression Of SARS-CoV-2 Infection
High-Capacity Serological Assay Developed for Celiac Disease
Cord Blood IgE Levels Tied To Allergy, Asthma Rates
Blood Abnormalities Found in People with Long Covid
Glypican-3 Is Associated With Impaired Outcome in Merkel Cell Carcinoma
The Immunology channel of LabMedica deals with diagnostic techniques and immuonassays such as ELISA, pregnancy tests, immunoblotting, immunohistochemical staining, serology, and associated hardware.